Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepadif capsule vs Legalon capsule in chronic liver disease
KCT0001480Phase 4Recruiting
- Sponsor
- Celltrion Pharm
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of silibinin in chronic liver disease (CLD) (2 arms), sponsored by Celltrion Pharm. Started Nov 2014; status: recruiting.
02
Drugs
silibinin
03
Conditions
chronic liver disease (CLD)
Beyond the preview
Go deeper on KCT0001480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001480.